Oxford Vaccine to roll out by 2020 end, results show high possibility

Possible good news is on our way finally!
As the human trials of India’s indigenous COVAXIN are set to begin in AIIMS-Delhi, Redkar Hospital in Goa and Bhubaneswar’s Institute of Medical Sciences and SUM Hospital. 2020 might see a scientific breakthrough of sorts, with more than 3 vaccines entering into their final stages of human trials, hopefully we might see the end of this pandemic if everything goes well.

The major 2 vaccines on whom the whole world has an eye on are – Oxford University and AstraZeneca Plc and China’s CanSino Biologics – induced immune responses in healthy volunteers without causing dangerous side effects, according to studies published on Monday in The Lancet.

In addition, WHO has recognized that over 20 potential coronavirus vaccine candidates are at the human trial stages and almost half of those are being developed by Chinese firms. One such is Sinovac. WHO has said that along with Oxford, “good news” in results shown by a Chinese firm. Chinese pharmaceutical firm Sinovac is the only third in the world to enter Phase 3 trials. The large scale testing is set to begin in six states in Brazil. Sinovac has also received a nod for Phase 3 trials in Bangladesh.